Connect with us
European Gaming Congress 2024

Artificial Intelligence

Laboratory Information Management System (LIMS) Market worth $3.3 billion | MarketsandMarkets

Published

on

laboratory-information-management-system-(lims)-market-worth-$3.3-billion-|-marketsandmarkets

CHICAGO, July 7, 2023 /PRNewswire/ — The Laboratory Information Management System (LIMS) industry is poised for remarkable growth in the near future as laboratories across various sectors increasingly recognize the need for efficient data management and streamlined workflows. LIMS, a software-based solution that automates and centralizes laboratory operations, is becoming indispensable in today’s data-driven scientific landscape. In the coming years, we can expect LIMS to evolve with advancements in technology, offering improved integration with instruments, enhanced data analytics capabilities, and seamless integration with other laboratory systems. The industry will witness a surge in demand as laboratories seek to optimize sample tracking, data organization, compliance with regulatory standards, and collaboration among researchers. Moreover, the integration of emerging technologies such as artificial intelligence, machine learning, and cloud computing will further revolutionize LIMS, enabling advanced data analysis, predictive analytics, and remote access capabilities. As laboratories continue to generate massive amounts of data, LIMS will play a vital role in extracting valuable insights, accelerating scientific discoveries, and driving innovation across industries ranging from pharmaceuticals and healthcare to environmental monitoring and forensic sciences. The future of the LIMS industry holds immense potential as it empowers laboratories to operate more efficiently, improve data integrity, and make significant contributions to scientific advancements.      
Laboratory Information Management System (LIMS) Market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $3.3 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growing popularity of cloud-based LIMS, use of LIMS in cannabis industry, significant growth potential in emerging markets are some of the key factors that offer opportunities to the market during the forecast period. However, the dearth of trained professionals, and interfacing challenges with informatics software are some of the factors challenging the market growth to some extent.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250610373
Browse in-depth TOC on “Laboratory Information Management System (LIMS) Market”161 – Tables46 – Figures254 – Pages
Laboratory Information Management System (LIMS) Market Scope:
Report Coverage
Details
Market Revenue in 2023
$1.6 billion
Estimated Value by 2028
$3.3 billion
Growth Rate
Poised to grow at a CAGR of 14.6%
Market Size Available for
2021–2028
Forecast Period
2023–2028
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Type, Component, Deployment model, and Industry
Geographies Covered
North America, Europe, Asia, and Rest of the world
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Significant growth in emerging markets
Key Market Drivers
Increasing focus on improving the efficiency of laboratories
 
The cloud-based segment is expected to register a substantial growth in the laboratory information management systems market, by deployment mode
The cloud-based segment is expected to register a substantial growth in the laboratory information management systems market, by deployment mode. This growth can be attributed to advantages of this deployment model, such as cost-effectiveness and ease of use. Factors such as on-demand self-serving analytics, their highly adaptable nature, ease of use, affordability, reliability, no upfront capital investment for hardware, extreme capacity flexibility, and a pay-as-you-go pricing model have also ensured the high growth of cloud-based LIMS.
Asia is to witness a considerable growth rate during the forecast period.
The Asian market is projected to grow at a considerable CAGR during the forecast period. Factors such as increasing medical tourism, growing investments expected to bring about the creation of new market participants, growing emergence of various technologies, and the rising foreign direct investments by North American and European pharmaceutical and biotechnology firms in Asia are anticipated to drive the development of laboratory information management systems applications in the Asia Pacific region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=250610373
Laboratory Information Management System (LIMS) Market Dynamics:
Drivers:
Increasing focus on improving the efficiency of laboratoriesRestraints:
Limited adoption of LIMS in small and medium-sized companiesOpportunities:
Significant growth in emerging marketsChallenges:
A dearth of trained professionalsKey Market Players:
LabWare (US), LabVantage Solutions Inc. (US), Thermo Fisher Scientific (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies (US), LabLynx, Inc. (US), Dassault Systèmes (France), Labworks LLC (US), Autoscribe Informatics (a wholly owned subsidiary of Autoscribe Limited) (US), Accelerated Technology Laboratories (ATL) (US), CloudLIMS (US), Computing Solutions, Inc. (US), GenoLogics Inc. (an Illumina Company) (Canada), Siemens (Germany), Novatek International (Canada), Ovation (US), Clinsys (US) are the major players in this market. These companies are majorly focusing on the strategies such as agreements, collaborations, partnerships, and service launches in order to remain competitive and further increase their share in the market.
Recent Developments:
In October 2022, LabVantage Solutions, Inc. (US) and Biomax Informatics AG (Germany) announced the closure of their merger agreement. The merger aims to enhance scientific data contextualization, accelerate product development, and provide innovative capabilities for the life science and bio-manufacturing industries.In March 2022, LabWare (US), acquired data analytics firm CompassRed (US). The merger aimed to create a LabWare Data Analytics Innovation Center and accelerate the transformation of data into actionable knowledge. The acquisition allowed LabWare to expand its services and establish a global presence.In March 2022, Thermo Fisher Scientific, Inc. (US) and Symphogen (Denmark) announced the continuation of their collaboration to provide innovative tools and workflows for the efficient characterization of complex therapeutic proteins in biopharmaceutical discovery and development laboratoriesGet 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=250610373
Laboratory Information Management System (LIMS) Market Advantages:
Data Centralization and Organization: LIMS provides a centralized platform for storing, managing, and organizing laboratory data. It eliminates the need for manual record-keeping and paper-based systems, reducing the risk of errors, data loss, and inefficient workflows. LIMS enables laboratories to efficiently track samples, manage test results, and maintain comprehensive records, ensuring data integrity and facilitating easy access to information.Streamlined Workflows and Increased Efficiency: LIMS automates various laboratory processes, including sample registration, tracking, and analysis. It standardizes workflows, reduces manual intervention, and optimizes resource allocation, leading to increased operational efficiency, faster turnaround times, and improved productivity. LIMS also enables seamless collaboration among researchers and departments, facilitating information sharing and enhancing overall laboratory performance.Quality Control and Regulatory Compliance: LIMS incorporates built-in quality control measures and ensures adherence to regulatory standards and industry guidelines. It enables laboratories to implement standardized protocols, monitor quality parameters, and track instrument calibration and maintenance schedules. By automating data entry and validation, LIMS minimizes errors and supports compliance with regulatory requirements, such as Good Laboratory Practices (GLP) and ISO standards.Enhanced Data Analysis and Reporting: LIMS offers powerful data analysis and reporting capabilities, enabling laboratories to derive valuable insights from their data. It provides tools for data visualization, trend analysis, and statistical calculations, facilitating informed decision-making and driving scientific discoveries. LIMS also generates customizable reports and audit trails, simplifying data interpretation, and facilitating compliance reporting and regulatory audits.Scalability and Integration: LIMS systems are designed to scale with the evolving needs of laboratories. They can accommodate increasing sample volumes, expanding test menus, and changing regulatory requirements. LIMS also integrates with various laboratory instruments and systems, such as analytical instruments, electronic laboratory notebooks (ELNs), and laboratory automation systems, enabling seamless data transfer and interoperability.Data Security and Integrity: LIMS ensures data security and integrity by implementing robust access controls, user authentication, and data encryption. It safeguards sensitive and confidential information, protects against unauthorized access or data tampering, and maintains an audit trail of all activities. LIMS also provides data backup and disaster recovery mechanisms, minimizing the risk of data loss and ensuring business continuity.In summary, the Laboratory Information Management System (LIMS) market offers advantages such as data centralization, streamlined workflows, increased efficiency, quality control, enhanced data analysis, scalability, integration capabilities, and data security. These advantages make LIMS a crucial tool for laboratories, enabling them to operate more efficiently, improve data accuracy, and comply with regulatory standards while facilitating scientific advancements and innovation.
Laboratory Information Management System (LIMS) Market – Report Highlights:
The North American region offers potential growth opportunities for most product manufacturers, owing to its high per-capita healthcare expenditure and higher innovation in technologies in laboratory systems such as integration with ERP, CDS. Easy accessibility to advanced healthcare, growth in the number of biobanks are significant factors supporting the market growth.
In the latest edition, market sizing and forecasting has been done at a more granular level, also changes in trends and forecasts have been incorporated as per the market scenario.
Market Overview: This edition includes updated market dynamics and market ecosystems specific to the laboratory information management systemsmarket.Industry Trends: This new edition includes an updated market map, value chain analysis, revenue shift analysis, case studies, technology analysis, market ecosystem, regulatory landscape, Porter’s Five Forces analysis, and trends/disruptions impacting customers’ businesses that are specific to the laboratory information management system (LIMS) market.Company Profiles: In this edition, 25 players have been profiled, and the product portfolios of the key players have been updated. It also includes updated financial information from 2020 to 2023 (wherever available).Recent Developments: Recent developments help understand the market trends and growth strategies the key players adopt. For instance, partnerships and collaborations increased during 2020–2023 in this market. Therefore, updated information for the mentioned period is provided.Latest Product Portfolio: Tracking the products offered by the companies helps improve market segmentation analysis. This edition provides updated product portfolios of the companies profiled.Company Evaluation Quadrant: The updated company evaluation quadrant in this edition covers a comprehensive study of the key vendors offering laboratory information management systems. Vendors are placed in either of the four categories: stars, emerging leaders, participants, and pervasive players. The top 25 companies operating in the market have been evaluated in this section.Startup/SME Evaluation Quadrant: The updated startup/SME evaluation quadrant in this edition covers a comprehensive study of the startups/SMEs offering laboratory information management systems. Vendors are placed in either of the four categories: progressive companies, responsive companies, dynamic companies, and starting blocks. Seven startups/SMEs operating in the market have been evaluated in this section.Recession Impact: The current edition of the report considers the ongoing economic recession and provides an impact analysis of the same. Detailed qualitative insights for recession impact by region have been provided across the regional analysis section.Related Reports:
Lab Automation Market – Global Forecasts to 2028
Laboratory Information System Market – Global Forecasts to 2028
Healthcare Cloud Computing Market – Global Forecasts to 2027
Healthcare Analytics Market – Global Forecasts to 2027
Laboratory Informatics Market – Global Forecasts to 2026
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Insight: https://www.marketsandmarkets.com/ResearchInsight/laboratory-information-management-systems-market.aspVisit Our Website: https://www.marketsandmarkets.com/Content Source: https://www.marketsandmarkets.com/PressReleases/laboratory-information-management-systems.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
 
View original content:https://www.prnewswire.co.uk/news-releases/laboratory-information-management-system-lims-market-worth-3-3-billion–marketsandmarkets-301871799.html

Continue Reading
Advertisement
Stake.com

Artificial Intelligence

Transforming Healthcare with AI: Yidu Tech’s Gong Rujing at Summer Davos

Published

on

transforming-healthcare-with-ai:-yidu-tech’s-gong-rujing-at-summer-davos

DALIAN, China, July 1, 2024 /PRNewswire/ — “AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry.” At the 15th Annual Meeting of the New Champions, also known as Summer Davos, Ms. Gong Rujing (Yingying), Chairwoman and Founder of Yidu Tech, was invited as a distinguished representative of the healthcare technology sector. She shared her unique insights into the future of AI in healthcare during the thematic dialogue on “Healthcare Analytics, Not Moving Fast Enough.”

This year marks the 10th anniversary of Yidu Tech and Ms. Gong Rujing’s decade-long dedication to the healthcare industry. From the inception of her entrepreneurial journey 10 years ago, she has been driven by the mission to leverage the power of technology to deliver precise healthcare to every individual.
Ms. Gong described the past decade as a journey filled with miracles and achievements. During this period, Yidu Tech has progressively established close collaborations with key stakeholders in the healthcare industry, including government agencies, hospitals, pharmaceutical companies, insurance firms, experts, and clinicians. As of March 31, 2024, Yidu Tech’s “AI Medical Brain” YiduCore has been authorized to process and analyze over 5 billion medical records, covering more than 2,500 hospitals.
In AI-powered clinical research, Yidu Tech has supported researchers and clinicians in producing over 240 high-level papers, accelerating the application of research outcomes. Additionally, Yidu Tech provides clinical trial services to globally renowned pharmaceutical companies, helping them optimize trial processes, reduce costs, and bring new drugs to market more swiftly, ultimately benefiting patients. In healthcare management, Yidu Tech’s AI technology plays a crucial role by analyzing vast amounts of medical data to provide comprehensive decision support to healthcare administrators, helping them optimize resource allocation and improve service efficiency.
“We are now entering a new era of AI technology.” The development of large language model technologies has opened up new possibilities across various industries. Yidu Tech has independently developed a large language model specific to the medical field and is advancing its application across the entire healthcare industry chain. The goal is to promote further progress and innovation through new AI technologies. However, Ms. Gong also emphasized that the healthcare industry is professional, complex, and sensitive, and the application of new technologies must address challenges such as data security, privacy protection, and ethics.
“Data security and privacy protection are fundamental to the development of AI technology and medical big data technology. We must ensure that all stakeholders are satisfied with compliance, security, accessibility, and privacy protection.”
“AI technology still has a long way to go.” She called on policymakers, healthcare institutions, and technology companies to work together to realize the immense potential of healthcare data. Ms. Gong highlighted that building trust is key, and enhancing data operability is essential to fully unleash the power of data. “It’s not just about better data quality; it’s about a better future for health.”

View original content:https://www.prnewswire.co.uk/news-releases/transforming-healthcare-with-ai-yidu-techs-gong-rujing-at-summer-davos-302186561.html

Continue Reading

Artificial Intelligence

Yidu Tech’s FY2024 results: existing business achieves first full-year profit on adjusted EBITDA

Published

on

yidu-tech’s-fy2024-results:-existing-business-achieves-first-full-year-profit-on-adjusted-ebitda

HONG KONG, July 1, 2024 /PRNewswire/ — On June 27, 2024, Yidu Tech Inc. (the ”Company” or ”Yidu Tech”) (2158.HK), a leader in China’s AI medical industry, announced its results for the 2024 fiscal year. During the reporting period, the Company recorded revenue of RMB 807.1 million. Gross profit margin in FY2024 increased to 42.1% from 34.1% in FY2023, representing an increase of 8 percentage points, hitting a record high. Adjusted net loss narrowed from RMB 448.7 million in FY2023 to RMB158.1 million, down 64.8% year-on-year. The management of Yidu Tech said at the annual results conference the next day that excluding strategic investments in proprietary large language model, non-cash items, and non-operating items, the adjusted EBITDA for our current business has achieved profit, moving from a RMB 327 million loss to a profit of RMB 31.1 million for the first time this fiscal year.

Management added that as of market close on June 27, the Company’s P/B ratio has decreased to 1.06. Not including the valuation of its domestic and international businesses, its market value is still lower than its fund reserves on hand. As such, management believes that the Company’s share price is still severely undervalued. Notably, renowned sovereign fund BIA has continually increased its shareholding of Yidu Tech by 21.50% over the past two months. The management is confident in the Company’s long-term growth potential and hopes to continually create innovative technologies and increase returns to its shareholders.
In FY2024, Yidu Tech focused on its core business, improving internal operating efficiency and earning quality. Among its earnings, revenue from its big data platform and solutions segment reached RMB 313.6 million, an increase of 41.4% year-on-year. Revenue from its life science solutions segment reached RMB 324.0 million, up 28.1% year-on-year and the gross margin increased by 14.6 percentage points to a historical high of 32.1%. Revenue from its health management platform and solutions segment reached RMB 169.5 million, and the gross profit margin of this segment was 58.1%, representing a year-on-year increase of 17.4 percentage points.
During the reporting period, the Company has continued the development and training of large language model in the medical vertical field based on 500 billion fine-trained Tokens, with model training for 6B, 13B, and 70B parameters completed.

View original content:https://www.prnewswire.co.uk/news-releases/yidu-techs-fy2024-results-existing-business-achieves-first-full-year-profit-on-adjusted-ebitda-302185986.html

Continue Reading

Artificial Intelligence

Lucinity’s AI Innovation Recognized at Microsoft’s Prestigious Global Partner Awards 2024

Published

on

lucinity’s-ai-innovation-recognized-at-microsoft’s-prestigious-global-partner-awards-2024

REYKJAVIK, Iceland, June 28, 2024 /PRNewswire/ — Lucinity has been recognized as a finalist in the AI Innovation category at the prestigious Microsoft Global Partner Awards 2024, recognizing its breakthrough AI solution and contribution to financial security through its collaboration with Microsoft. 

Lucinity beat more than 4,700 companies to be named a finalist at the annual Microsoft Global Partner Awards, which highlights Lucinity’s achievements as a Microsoft partner in optimizing business processes, improving customer experiences, and opening new pathways for digital transformation.
This achievement comes in addition to winning two prestigious awards at Microsoft Partner Awards 2024 last month, including Partner of the Year – Iceland, and the Sustainability and Social Impact award.
The accolade recognizes Lucinity’s significant advancements in AI for financial crime operations, particularly through their AI-powered copilot, Luci. This innovative solution utilizes Microsoft Azure OpenAI technology to integrate advanced generative AI into financial crime investigations and regulatory compliance, optimizing processes and saving significant time and resources for financial institutions.
The Lucinity platform streamlines compliance, provides instant insights, and reduces typical investigation times from three hours to just 30 minutes. The technology can also save financial institutions an estimated $100 million in productivity savings, as well as savings in training and recruitment.
Microsoft comments on Lucinity’s award recognition, saying “Financial crime profoundly impacts our global community, with far-reaching economic, security, and social implications. It can harm a country’s reputation and increase exposure to criminal activities, emphasizing the critical need for robust anti-money laundering initiatives and persistent vigilance. Lucinity, with their innovative AI solutions, has really tried to combat this huge global challenge. They use ‘Human AI’ to enhance financial crime prevention, combining AI with human expertise for efficient, user-friendly solutions. Additionally, Lucinity has developed a tool called Luci, an AI-powered copilot that helps transform financial crime prevention from a process that took hours to one that takes minutes.”
“Being recognized as a finalist at the Microsoft Global Partner Awards is  validation of our impactful collaboration with Microsoft in financial crime operations. Our partnership has been pivotal for our innovations, enabling us to use Azure OpenAI to bring tools like Luci to life and deliver impactful results for our clients,” says Guðmundur Kristjánsson, Founder & CEO of Lucinity.
Contact:Name: Celina PabloEmail: [email protected]: +354 792 4321
Logo: https://mma.prnewswire.com/media/2208676/4669079/Lucinity_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lucinitys-ai-innovation-recognized-at-microsofts-prestigious-global-partner-awards-2024-302186091.html

Continue Reading

Trending